Roswell Park Welcomes New Vice Chair of Clinical Affairs: Dr. Peter Maslak
Peter Maslak, MD, is an expert Hematologic Oncologist, joining Roswell Park as Vice Chair of Clinical Affairs, Director of Flow Cytometry in the Immune Monitoring Shared Resource and the Technical Director of the Flow Cytometry Lab.
Clinical Scorecard: Roswell Park Welcomes New Vice Chair of Clinical Affairs: Dr. Peter Maslak
At a Glance
Category Detail
Condition Hematologic malignancies and immune system monitoring Key Mechanisms Clinical flow cytometry and immunophenotyping for immune monitoring and cellular therapies Target Population Patients undergoing cancer treatment, including CAR T-cell therapy and transplant recipients Care Setting Academic cancer center with integrated clinical and research facilities
Key Highlights
Dr. Peter Maslak brings over 25 years of expertise in clinical flow cytometry and immunophenotyping. Immune monitoring supports expansion of CAR T-cell therapy and transplant services at Roswell Park. Flow cytometry laboratory at Roswell Park has a historic and cutting-edge role in cancer research and clinical care. Guideline-Based Recommendations
Diagnosis
Utilize flow cytometry and immunophenotyping for accurate diagnosis of hematologic malignancies. Management
Incorporate immune monitoring to assess treatment response in CAR T-cell therapy and transplant patients. Tailor therapy choices based on individual immune response and genetic factors. Monitoring & Follow-up
Perform longitudinal immune monitoring to evaluate how infused cells interact with tumor and host. Use laboratory immune monitoring to optimize personalized cancer treatment plans. Risks
Recognize variability in immune responses due to genetic differences among patients. Patient & Prescribing Data
Cancer patients receiving cellular therapies and transplants
Immune monitoring helps determine efficacy and guides personalized therapy selection to improve outcomes.
Clinical Best Practices
Collaborate across disciplines to integrate immune monitoring data into clinical decision-making. Train clinicians and scientists in flow cytometry techniques to enhance research and patient care. Leverage shared resource laboratories to support translational research and clinical applications. References
